Statins—beyond lipids in CKD

Nephrology Dialysis Transplantation

Volumn 26, Issue 2, 2011, Pages 407-410

  Amann, Kerstin ^a   Benz, Kerstin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

endothelial cell; mesangial cells; pleiotropic effects; podocytes; statins

Indexed keywords

ATORVASTATIN; CYCLIN DEPENDENT KINASE 2; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 17; LIPID; LOW DENSITY LIPOPROTEIN; MEVINOLIN; PLACEBO; PRAVASTATIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SIMVASTATIN;

ALBUMINURIA; ANTIOXIDANT ACTIVITY; CD4+ T LYMPHOCYTE; CHRONIC KIDNEY DISEASE; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENDOTHELIAL DYSFUNCTION; GLOMERULONEPHRITIS; HUMAN; IMMUNOMODULATION; KIDNEY FUNCTION; KIDNEY INJURY; MESANGIUM CELL; NONHUMAN; NOTE; PLEIOTROPY; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RENAL PROTECTION; SURVIVAL; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DRUG EFFECT; EDITORIAL; KIDNEY; KIDNEY DISEASE;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY; KIDNEY DISEASES;

EID: 79551493893     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq662     Document Type: Note

References (30)

1. Ridker PM, Danielson E, Fonseca FA et al. JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207
2. Agarwal R. Effects of statins on renal function. Mayo Clin Proc 2007; 82: 1381-1390
3. Kasiske BL, O'Donnell MP, Schmitz PG et al. Renal injury of dietinduced hypercholesterolemia in rats. Kidney Int 1990; 37: 880-891
4. KeaneWF, O'DonnellMP, Kasiske BL et al. Lipids and the progression of renal disease. J Am Soc Nephrol 1990; 1: S69-S74
5. Campese VM, Park J. HMG-CoA reductase inhibitors and renal function. Clin J Am Soc Nephrol 2007; 2: 1100-1103
6. Wanner C, Krane V, März W et al. German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
7. Fellström BC, Jardine AG, Schmieder RE et al. AURORA Study Group. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407
8. Tonelli M, Moyé L, Sacks FM et al. Cholesterol and Recurrent Events Trial Investigators. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol 2003; 14: 1605-1613
9. Sandhu S, Wiebe N, Fried LF et al. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol 2006; 17: 2006-2016
10. Levi M. Do statins have a beneficial effect on the kidney? Nat Clin Pract Nephrol 2006; 2: 666-667
11. Douglas K, O'Malley PG, Jackson JL. Meta-analysis: the effect of statins on albuminuria. Ann Intern Med 2006; 145: 117-124
12. Sukhija R, Bursac Z, Kakar Pet al. Effect of statins on the development of renal dysfunction. Am J Cardiol 2008; 101: 975-979
13. Strippoli GF, Navaneethan SD, Johnson DW et al. Effects of statins in patients with chronic kidney disease: meta-analysis and metaregression of randomised controlled trials. BMJ 2008; 336: 645-651
14. Fried LF. Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease. Kidney Int 2008; 74: 571-576
15. Yoshimura A, Inui K, Nemoto Tet al. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis. J Am Soc Nephrol 1998; 9: 2027-2039
16. Park YS, Guijarro C, Kim Y et al. Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats. Am J Kidney Dis 1998; 31: 190-194
17. Khwaja A, Sharpe CC, Noor M et al. The role of geranylgeranylated proteins in human mesangial cell proliferation. Kidney Int 2006; 70: 1296-1304
18. Goppelt-Struebe M, Hahn A, Iwanciw D et al. Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins). Mol Pathol 2001; 54: 176-179
19. Bussolati B, Deregibus MC, Fonsato Vet al. Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway. J Am Soc Nephrol 2005; 16: 1936-1947
20. Cormack-Aboud FC, Brinkkoetter PT, Pippin JW et al. Rosuvastatin protects against podocyte apoptosis in vitro. Nephrol Dial Transplant 2009; 24: 404-412
21. Hartner A, Klanke B, Cordasic N et al. Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone- acetate-salt hypertension. J Hypertens 2009; 27: 376-385
22. Shibata S, Nagase M, Fujita T. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling. J Am Soc Nephrol 2006; 17: 754-764
23. Sakurai N, Kuroiwa T, Ikeuchi H et al. Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy. Nephrol Dial Transplant 2009; 24: 2378-2383
24. Zhou MS, Schuman IH, Jaimes EA et al. Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol 2008; 295: F53-F59
25. Zhou MS, Jaimes EA, Raij L. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress. Hypertension 2004; 44: 186-190
26. Ito D, Ito O, Mori N et al. Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats. J Hypertens 2010; 28: 2278-2288
27. Knight SF, Yuan J, Roy S et al. Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension. Am J Physiol Renal Physiol 2010; 298: F86-F94
28. Eller P, Eller K, Wolf AM et al. Atorvastatin attenuates murine antiglomerular basement membrane glomerulonephritis. Kidney Int 2010; 77: 428-435
29. Dimmeler S, Aicher A, Vasa M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001; 108: 391-397
30. Lavi R, Zhu XY, Chade AR et al. Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 2010; 30: 976-983